HPGC Renmintongtai Pharmaceutical (SHSE:600829) Ending Cash Position : ¥1,030 Mil (As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is HPGC Renmintongtai Pharmaceutical Ending Cash Position?

HPGC Renmintongtai Pharmaceutical's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥1,030 Mil.

HPGC Renmintongtai Pharmaceutical's quarterly Ending Cash Position increased from Sep. 2023 (¥949 Mil) to Dec. 2023 (¥1,237 Mil) but then declined from Dec. 2023 (¥1,237 Mil) to Mar. 2024 (¥1,030 Mil).

HPGC Renmintongtai Pharmaceutical's annual Ending Cash Position increased from Dec. 2021 (¥515 Mil) to Dec. 2022 (¥966 Mil) and increased from Dec. 2022 (¥966 Mil) to Dec. 2023 (¥1,237 Mil).

HPGC Renmintongtai Pharmaceutical Ending Cash Position Historical Data

The historical data trend for HPGC Renmintongtai Pharmaceutical's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HPGC Renmintongtai Pharmaceutical Ending Cash Position Chart

HPGC Renmintongtai Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

367.21

416.82

514.58

965.55

1,236.53

HPGC Renmintongtai Pharmaceutical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															993.25	1,205.37	948.78	1,236.53	1,029.86

HPGC Renmintongtai Pharmaceutical Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

HPGC Renmintongtai Pharmaceutical's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	965.548	+	270.986
	=	1,237

HPGC Renmintongtai Pharmaceutical's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1236.516	+	-206.657
	=	1,030

HPGC Renmintongtai Pharmaceutical Ending Cash Position Related Terms

Thank you for viewing the detailed overview of HPGC Renmintongtai Pharmaceutical's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

HPGC Renmintongtai Pharmaceutical (SHSE:600829) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HPGC Renmintongtai Pharmaceutical Corp (SHSE:600829) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

No. 76 Hengshan Road, Nangang District, Heilongjiang Province, Harbin, CHN, 150076

Website

http://www.sanjing.com.cn

HPGC Renmintongtai Pharmaceutical Corp, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co Ltd is engaged in the production and sale of pharmaceuticals products in China.

Executives

Yue Xian Zhi	senior management
Zhang Li Jun	Director

HPGC Renmintongtai Pharmaceutical (SHSE:600829) Headlines

No Headlines